Related Experiment Video
Updated: May 10, 2026
10:44
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
10.2K
The refined Pathways to Cures Research Roadmap for multiple sclerosis cures.
Bruce F Bebo1, Brenda L Banwell2, Caroline C Whitacre1
1National Multiple Sclerosis Society, New York, NY, USA.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|August 30, 2024
Summary
A global summit updated the Pathways to Cures Research Roadmap for multiple sclerosis (MS). This strategic framework aims to accelerate the discovery of MS cures by enhancing research collaboration and resource coordination.
Area of Science:
- Neuroimmunology
- Central Nervous System Disorders
- Chronic Disease Research
Background:
- Multiple sclerosis (MS) is a chronic, immune-mediated central nervous system disease affecting millions globally.
- Despite treatment advances, a cure for MS remains elusive.
Purpose of the Study:
- To accelerate the development of multiple sclerosis (MS) cures.
- To update the Pathways to Cures Research Roadmap based on current disease understanding.
- To foster global research coordination and identify high-potential scientific areas.
Main Methods:
- A Global Summit convened nearly 200 international experts, including scientists, clinicians, policymakers, funders, and individuals with MS.
- The summit focused on refining the existing research roadmap for MS cures.
Main Results:
- A refined roadmap with three key pathways targeting opportunities for cure-discovery was developed.
- Recommendations include improving global data sharing, enhancing research collaboration, ensuring sustained funding, and promoting diversity, equity, and inclusion.
Conclusions:
- The updated roadmap offers a strategic framework to address MS complexities.
- It aims to advance prevention, treatment, and cure strategies for multiple sclerosis.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...